GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection
Public ClinicalTrials.gov record NCT01353248. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Open-Label Study of GS-5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) to Treatment-Naive Subjects With Chronic Genotype 1 HCV Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this phase 2 study is to determine whether 30 mg or 90 mg of GS-5885 when given with GS-9451, Tegobuvir and Ribavirin (RBV) for 12 or 24 weeks is effective, safe and tolerable in the treatment of Chronic Genotype 1 HCV Infection.
Study identification
- NCT ID
- NCT01353248
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 141 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2011 (Type not available)
- Primary completion
- Oct 2012 (Actual)
- Completion
- Mar 2013 (Actual)
- Last update posted
- Dec 20, 2013
2011 – 2013
United States locations
- U.S. sites
- 42
- U.S. states
- 22
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Gastroenterology Associates, P.C. | Birmingham | Alabama | 35209 | — |
| Digestive Health Specialists of the Southeast | Dothan | Alabama | 36305 | — |
| Advanced Clinical Research Institute | Anaheim | California | 92801 | — |
| Southern California Liver Centers | Coronado | California | 92118 | — |
| UCSF Fresno Medical Education Program (MEP) | Fresno | California | 93721 | — |
| Stanford University School of Medicine | Palo Alto | California | 94304 | — |
| University of California San Diego | San Diego | California | 92103 | — |
| Kaiser Permanente | San Diego | California | 92154 | — |
| UCSF | San Francisco | California | 94143 | — |
| Walter Reed Army Medical Center | Washington D.C. | District of Columbia | 20307 | — |
| Bach and Godofsky Infectious Diseases | Bradenton | Florida | 34209 | — |
| University of Florida - Gainesville | Gainesville | Florida | 32610 | — |
| Borland-Groover Clinic | Jacksonville | Florida | 32256 | — |
| University of Miami School of Medicine | Miami | Florida | 33136 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| Orlando Clinical Research Center | Orlando | Florida | 32809 | — |
| Gastrointestinal Specialists of Georgia PC | Marietta | Georgia | 30060 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| Private Practice | Opelousas | Louisiana | 70570 | — |
| Johns Hopkins University | Lutherville | Maryland | 21093 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02115 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Gastrointestinal Associates, PA | Jackson | Mississippi | 39202 | — |
| University of New Mexico | Albuquerque | New Mexico | 87131 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599-7584 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Options Health Research, LLC | Tulsa | Oklahoma | 74104 | — |
| University of Pennsylvania Hospital | Philadelphia | Pennsylvania | 19104 | — |
| Gastro One | Germantown | Tennessee | 38138 | — |
| Memphis Gastroenterology Group | Germantown | Tennessee | 38138 | — |
| Columbia Medical Group, The Frist Clinic | Nashville | Tennessee | 37203 | — |
| Nashville Gastrointestinal Specialists, Inc | Nashville | Tennessee | 37211 | — |
| Baylor University Medical Center | Dallas | Texas | 75246 | — |
| Research Specialists of Texas | Houston | Texas | 77030 | — |
| Alamo Medical Research | San Antonio | Texas | 78215 | — |
| Lifetree Clinical Research, LC | Salt Lake City | Utah | 84106 | — |
| Inova Fairfax Hospital - Center for Liver Diseases | Falls Church | Virginia | 22042 | — |
| Liver Institute of Virginia, Bon Secours Health System | Newport News | Virginia | 23602 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01353248, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 20, 2013 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01353248 live on ClinicalTrials.gov.